The Swiss pharmaceutical BioVersys has raised CHF 24.2 million in a first closing of its Series C round. This first closing was significantly oversubscribed by both existing and new investors from diverse geographies. The company intends
ImmunOs Therapeutics has closed an oversubscribed Series B financing round totaling USD 74 million. The round was led by new investors Samsara BioCapital, Lightspeed Venture Partners, and Gimv, and joined by new investors Mission BioCapital, GL
After its successful product launch in September 2021, Swiss fintech start-up Numerics has just closed a CHF 2.1 million pre-seed financing round led by Wingman Ventures and Seed X Liechtenstein. Numarics is Zurich based start-up that offers
Werder–Viganò’s partner Gregori Werder has been elected to the foundation council of the Sophie Guyer Foundation by the Pfäffikon Municipal Council in May 2022. The steering committee of the Sophie Guyer retreat center
GP Investments, majority shareholder of Spice Private Equity, has pre-announced its public tender offer for all publicly held shares in SIX listed Spice Private Equity. GP Investments intends to increase its equity share in Spice
Investment Latour has, through its wholly-owned subsidiary Swegon Group, acquired Barcol-Air, a leading supplier of radiant ceiling systems. The acquisition of Barcol-Air means that Swegon continue to build on its already strong position within radiant
Junod, Muhlstein, Lévy & Puder advised Barcelona-based hospitality recruitment platform Hosco on a successful EUR 3,400,000 intermediate Series-A financing round for hospitality network. Created in 2011 the hospitality recruitment platform Hosco is aimed at companies
Gustoso Group expands into Switzerland with an investment in Burgermeister Schweiz operating the Burgermeister and Cucina restaurants in Switzerland. The founder Aydin Yildirim remains invested with a significant stake. Munich-based Group operates roughly 80 restaurants in
Perfect Holding announced the completion of the reverse takeover transaction (RTO) with Kinarus, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel therapeutics for the treatment of viral, respiratory, and ophthalmic disease.
Wenger Vieli strengthens its team by incorporating three new female lawyers. Regula Elisabeth Haegi (pictured left) has joined the firm as counsel. She has served over twelve years as inhouse counsel and has management experience
